Szyper Linda M 4
4 · Neos Therapeutics, Inc. · Filed May 1, 2018
Insider Transaction Report
Form 4
Szyper Linda M
Director
Transactions
- Award
Stock Option (Right to Buy)
2018-04-27+12,500→ 12,500 totalExercise: $8.40Exp: 2028-04-27→ Common Stock (12,500 underlying)
Footnotes (1)
- [F1]This stock option will vest in equal quarterly installments over a two-year period which begins on April 27, 2018.